switching between glp-1 agonists ada #4 NN Clinical Use GLP-1 dose conversion chart and

Although the mechanisms leading to a blood pressure decrease during the treatment with GLP-1 agonists have not been fully elucidated it could be the result of an increased sodium and water excretion and/or inhibition of the RAAS activity 14

Semaglutide, a diabetes and weight loss medication most commonly sold under the brand names Ozempic and Wegovy, is under review by the World Anti-Doping Organization (WADA)

Bariatric procedures or surgery were go-to options for many people prior to GLP-1 medications

The SELECT trial was the first large, randomized study to show that a drug used for obesity could reduce cardiovascular disease, says Isaacs

Reaching higher daily protein needs can be challenging with reduced food intake and protein supplements can help fill those gaps